ClinConnect ClinConnect Logo
Search / Trial NCT06454487

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Cardiac Rehabilitation Hand Grip Training Blood Pressure

ClinConnect Summary

This clinical trial is investigating whether a specific type of exercise called isometric handgrip (IHG) training can lower resting blood pressure in people who are participating in cardiac rehabilitation. Cardiac rehabilitation is a program designed to help people recover from heart problems, and the researchers want to see if adding IHG training to the standard rehabilitation can provide additional benefits. In this study, eligible participants will be randomly divided into two groups: one group will do IHG training along with their regular rehabilitation exercises, and the other group will only participate in the standard rehabilitation program. Participants in the IHG group will use an inflatable ball for the training three times a week for 12 weeks and will be asked to measure and report their blood pressure at home.

To be eligible for this trial, participants must be adults aged 18 or older who can understand English and have been cleared by their healthcare provider to participate in exercise-based cardiac rehabilitation. They should also have a history of coronary artery disease but not other serious heart conditions. Throughout the study, researchers will check in with participants to see how they are doing and to understand how the IHG training affects their mental well-being. This study aims to help improve heart health and find out if the additional training is enjoyable and beneficial for those in cardiac rehabilitation.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Component adult (greater ≥ 18 years) who can provide informed consent.
  • Proficient in English (speaking, writing, and reading).
  • Medically cleared by the cardiac rehabilitation program to participate in exercise-based cardiac rehabilitation.
  • History of only coronary artery disease, the most common cardiovascular disease (CVD), which may include individuals with a previous myocardial infarction and/or procedure such as a percutaneous coronary intervention and/or coronary artery bypass grafting.
  • Minimum of "blue" level of technology capability (assigned by the cardiac rehabilitation program) indicating ability to use a phone and email for correspondence. Note: The majority of individuals who enroll in the cardiac rehabilitation program are assigned to this level.
  • No physical limitation(s) that would hinder the performance of isometric handgrip training.
  • Access to a blood pressure monitoring device to record at home measures.
  • Exclusion Criteria:
  • If the participant does not meet the inclusion criteria (identified above).
  • Moreover if an individual has a history of a CVD or disease-related complications (e.g., heart failure, atrial fibrillation, ventricular arrhythmias, aortic aneurysm, valve repair and/or replacement) and/or related procedures (e.g., placement of a pacemaker and/or implantable cardiac defibrillator) that is not coronary artery disease (as described in the inclusion criteria) they will be excluded.
  • Note: Individuals may have other comorbidities.

About London Health Sciences Centre Research Institute Or Lawson Research Institute Of St. Joseph's

The London Health Sciences Centre Research Institute, affiliated with Lawson Health Research Institute at St. Joseph's Health Care, is dedicated to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into practical applications, the institute fosters collaboration among leading researchers, clinicians, and healthcare professionals. It aims to improve patient outcomes and enhance the quality of care through rigorous investigation in areas such as cancer, cardiovascular health, and neuroscience. By integrating cutting-edge research with clinical practice, the institute plays a pivotal role in shaping the future of healthcare delivery in the community and beyond.

Locations

London, Ontario, Canada

Windsor, Ontario, Canada

Patients applied

0 patients applied

Trial Officials

Cheri McGowan, PhD

Principal Investigator

Windsor University and LawsonHRI

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported